Jeremiah Pharms Jr.

Career StatsD-

Year	Team	GP	Sacks	Tkl	TFL
Career		31	2.0	45	6.5
2025		3	0.0	3	1
2024		16	2.0	33	5
2023		12

Current Contract

Contract Value Index (CVI)

This Jeremiah Pharms Jr. signing represents a fair deal for New England, earning a solid C+ CVI as the Patriots add affordable depth to their defensive line rotation. At just $1M AAV with minimal guaranteed money, the risk is essentially zero for a depth piece who can contribute in limited snaps and provide insurance behind their established starters. The one-year structure gives both sides flexibility — Pharms gets a chance to prove he belongs in the league while the Patriots can evaluate his fit without long-term commitment. With only $300K guaranteed, New England can cut ties at any point if he doesn't make the roster, making this the type of low-risk flyer that championship-caliber organizations routinely execute. The contract reflects exactly what Pharms' current market value should be as a rotational defensive tackle, giving the Patriots another body in camp without hampering their salary cap flexibility for bigger moves.

Performance Analysis

Jeremiah Pharms Jr. grades at a D- as a Patriots defensive tackle who has been a rotational piece without making a significant impact. His 45 tackles and two sacks across 31 games over four seasons shows steady but unspectacular production from the interior. The 6.5 tackles for loss add some disruption value, and the 2024 season with 16 games was his most extensive action. His 2025 season was limited to just three games, suggesting he may have fallen down New England's depth chart. Pharms has been a useful body in the Patriots' rotation, but the D- grade reflects a player who has not developed into the kind of impactful defensive tackle that teams need in today's NFL.

Fan Sentiment

A low-risk depth move that adds rotational interior line presence for New England. Headlines highlight an improbable journey, including a Super Bowl LX appearance, suggesting surprising upside. His practice squad origins and waiver wire history signal he's a fringe roster player, not a long-term solution. Fans are intrigued by the underdog narrative but tempered in expectations given his marginal pedigree. Pharms Jr. projects as a camp-to-roster bubble player who must earn snaps through consistency.